Your browser doesn't support javascript.
loading
CXC chemokine ligand 4 (CXCL4) is predictor of tumour angiogenic activity and prognostic biomarker in non-small cell lung cancer (NSCLC) patients undergoing surgical treatment.
Spaks, Artjoms; Svirina, Darja; Spaka, Irina; Jaunalksne, Inta; Breiva, Donats; Tracums, Ilmars; Krievins, Dainis.
Afiliação
  • Spaks A; a Department of Thoracic Surgery , Pauls Stradins Clinical University Hospital , Riga , Latvia ;
  • Svirina D; b Department of Pathology , University of Latvia , Riga , Latvia ;
  • Spaka I; c Department of Molecular Biology , Riga Stradins University , Riga , Latvia ;
  • Jaunalksne I; d Department of Clinical Immunology , Pauls Stradins Clinical University Hospital , Riga , Latvia ;
  • Breiva D; a Department of Thoracic Surgery , Pauls Stradins Clinical University Hospital , Riga , Latvia ;
  • Tracums I; a Department of Thoracic Surgery , Pauls Stradins Clinical University Hospital , Riga , Latvia ;
  • Krievins D; e Department of Vascular Surgery , Pauls Stradins Clinical University Hospital , Riga , Latvia ;
Biomarkers ; 21(5): 474-8, 2016 Jul.
Article em En | MEDLINE | ID: mdl-27098116

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator Plaquetário 4 / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator Plaquetário 4 / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article